Logo di Merck & Co a Rahway, New Jersey, Stati Uniti
Molnupiravir, which would be the first oral antiviral medication for COVID-19 if it gets regulatory approval, could halve the chances of dying or being hospitalised for those most at risk of contracting severe COVID-19, clinical data has shown. Malaysia's Health Minister Khairy Jamaluddin said the government signed a letter of undertaking for the purchase on Thursday.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Malaysia buys 150,000 courses of Merck's COVID-19 pillKUALA LUMPUR: Malaysia has struck a deal with US drugmaker Merck to buy 150,000 courses of its experimental antiviral pill, the health ministry said on Thursday (Oct 7), joining other Asian countries in a rush to secure supplies. Molnupiravir, which would be the first oral antiviral medication for COV
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
South Korea secures 20,000 courses of Merck's COVID-19 pill, says PMSEOUL: South Korea has secured 20,000 courses of an experimental antiviral pill developed by Merck \u0026 Co for COVID-19 treatment, Prime Minister Kim Boo-kyum said on Wednesday (Oct 6), joining other Asian nations rushing to snap up supplies. Merck also announced on Wednesday a supply and purchase agreeme
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Australia to buy Merck's COVID-19 pillAustralia will buy 300,000 courses of an experimental antiviral pill made by Merck and Co.Prime Minister Scott Morrison made the announcement Tuesday (October 5).'These treatments mean that we're going to be able to live with the virus, so even in the unfortunate situation if you do contract the virus, then we'll have the treatments to ensure that we can lessen these symptoms, reduce the chance of you ending up on ICU which can put pressure on the hospital systems.'The pill, named Molnupiravir, would be the first oral antiviral medication for COVID-19 if it can get regulatory approval.Experts say it could halve the chances of dying or being hospitalized for people most at risk of getting severe COVID.Morrison said the capsules have to be taken twice a day for five days by adult patients for a course of ten.He also said the drug is expected to available in Australia by early next year if approved by the country's drug regulator.Australia is stepping up its vaccination rate as its largest cities Sydney and Melbourne go through weeks-long lockdowns.The national first-dose rate in adults pushed past 80% on Tuesday (October 5) morning. It comes as Victoria recorded the highest number of daily COVID infections of any state in the country since the start of the pandemic.1763 new infections were reported on Saturday (October 2).Australia has had some of the world's strictest border rules during the global health crisis, but aims to reopen next month for fully vaccinated citizens and permanent residents.
Source: YahooSG - 🏆 3. / 71 Read more »
S.Korea secures 20,000 courses of Merck's COVID-19 pill, says PMSouth Korea has secured 20,000 courses of an experimental antiviral pill developed by Merck & Co for COVID-19 treatment, Prime Minister Kim Boo-kyum said on Wednesday, joining other Asian nations rushing to snap up supplies. Merck also announced on Wednesday a supply and purchase agreement with Singapore https://www.reuters.com/business/healthcare-pharmaceuticals/merck-says-deal-signed-with-singapore-covid-19-antiviral-pill-2021-10-06, following Australia https://www.reuters.com/world/asia-pacific/australia-buy-300000-doses-mercks-covid-19-antiviral-pill-2021-10-04, while Thailand, Taiwan and Malaysia said they are in talks to buy it.
Source: YahooSG - 🏆 3. / 71 Read more »